Hypothesis: Antiplatelet Effects of Selective Serotonin Reuptake Inhibitors Cause Clinical Benefits on Cardiovascular Disease and Increase Risks of Bleeding
Hypothesis: Antiplatelet Effects of Selective Serotonin Reuptake Inhibitors Cause Clinical Benefits on Cardiovascular Disease and Increase Risks of Bleeding
Williams A , Hennekens CH. The role of aspirin in cardiovascular diseases—forgotten benefits?Expert Opin Pharmacother5:101-115, 2004
2.
Bakish D , Cavazzoni P, Chudzik J, et al. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psych41:181-190, 1997
3.
Butler J , Leonard BE. The platelet serotonergic system in depression and following sertraline treatment. Int J Clin Psychopharmacol3:341-347, 1988
4.
Helmeste DM , Tang SW, Reist C, Vu R. Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets. Eur J Pharmacol281:371-377, 1995
5.
Markovitz JH , Shuster JL, Chitwood WS, et al. Platelet activation in depression and effects of sertraline treatment: An open-label study. Am J Psychiatry157:1001-1008, 2000
6.
Musselman DL , Marzec UM, Manatunga A, et al. Platelet reactivity in depressed patients treated with paroxetine: Preliminary findings. Arch Gen Psychiatry57:871-882, 2000
7.
Alvarez JC , Gluck N, Arnulf I, et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine. Clin Pharmacol Ther66:611-624, 1999
8.
Serebruany VL , Gurbel PA, O’Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res43:451-462, 2001
9.
Shen WW , Swartz CM, Calhoun JW. Is inhibition of nitric oxide synthase a mechanism for SSRI-induced bleeding?Psychosomatics40:261-269, 1999
10.
Glassman AH , O’Connor CM, Califf RM, et al. Sertraline Antidepressant Heart Attack Randomized Trial (SAD-HEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA288:701-709, 2002
11.
Serebruany VL , Glassman AH, Malinin AI, et al. Sertraline AntiDepressant Heart Attack Randomized Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation108:931-944, 2003
12.
Stricker BH , Ottervanger JP, van der Klauw MM. Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993. Ned Tijdschr Geneeskd138:2111-2113, 1994
13.
Nelva A , Guy C, Tardy-Poncet B, et al. Hemorrhagic syndromes related to selective serotonin reuptake inhibitor (SSRI) antidepressants. Seven case reports and review of the literature. Rev Med Interne21:151-160, 2000
14.
Pai VB , Kelly MW. Bruising associated with the use of fluoxetine. Ann Pharmacother30:781-788, 1996
15.
Lake MB , Birmaher B, Wassick S, et al. Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence. J Child Adolesc Psychopharmacol10:31-38, 2000
16.
Mirsal H , Kalyoncu A, Pektas O. Ecchymosis associated with the use of fluoxetine: Case report. Turk Psikiyatri Derg13:321-324, 2002
17.
Cooper TA , Valcour VG, Gibbons RB, et al. Spontaneous ecchymoses due to paroxetine administration. Am J Med104:191-198, 1998
18.
Stanford MS , Patton JH. In utero exposure to fluoxetine HCl increases hematoma frequency at birth. Pharmacol Biochem Behav45:951-962, 1993
19.
Bassotti G , Nzepa FS, de Roberto G, et al. Symptomatic reversible duodenal compression due to iatrogenic retroperitoneal hematoma. Dig Liver Dis36:71-81, 2004
20.
Cailleux N , Marie I, Chretien MH, et al. Spontaneous hematoma: Thoughts about selective serotonin uptake inhibitors. J Mal Vasc25:61-64, 2000
21.
Vandel P , Vandel S, Kantelip JP. SSRI-induced bleeding: Two case reports. Therapie56:441-447, 2001
22.
Norred CL , Finlayson CA. Hemorrhage after the preoperative use of complementary and alternative medicines. AANA J68:211-220, 2000
23.
Sewnath ME , van Hillegersberg R, Koopman MM, et al. Increased perioperative blood loss during treatment with paroxetine. Ned Tijdschr Geneeskd146:1801-1802, 2002
24.
Dent LA , Orrock MW. Warfarin-fluoxetine and diazepamfluoxetine interaction. Pharmacotherapy17:171-172, 1997
25.
de Maistre E , Allart C, Lecompte T, et al. Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors. Am J Med113:531-532, 2002
26.
Dalton SO , Johansen C, Mellemkjaer L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study. Arch Intern Med163:51-64, 2003
27.
Weinrieb RM , Auriacombe M, Lynch KG, et al. A critical review of selective serotonin reuptake inhibitor-associated bleeding: Balancing the risk of treating hepatitis C-infected patients. J Clin Psychiatry64:1501-1510, 2003